TRUSELTIQ Trademark

Trademark Overview

On Monday, October 19, 2020, a trademark application was filed for TRUSELTIQ with the United States Patent and Trademark Office. The USPTO has given the TRUSELTIQ trademark a serial number of 90975538. The federal status of this trademark filing is REGISTERED as of Tuesday, October 26, 2021. This trademark is owned by QED Therapeutics, Inc.. The TRUSELTIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of cancer
truseltiq

General Information

Serial Number90975538
Word MarkTRUSELTIQ
Filing DateMonday, October 19, 2020
Status700 - REGISTERED
Status DateTuesday, October 26, 2021
Registration Number6541355
Registration DateTuesday, October 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, December 6, 2020
Primary Code005
First Use Anywhere DateThursday, June 17, 2021
First Use In Commerce DateThursday, June 17, 2021

Trademark Owner History

Party NameHELSINN HEALTHCARE S.A.
Party Type31 - New Owner After Registration
Legal Entity Type33 - NOT AVAILABLE
AddressPAZZALLO LUGANO 6912
CH
Party NameQED Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameQED Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameQED Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Trademark Events

Event DateEvent Description
Wednesday, November 24, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 26, 2021REGISTERED-PRINCIPAL REGISTER
Saturday, September 18, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 17, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 17, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 15, 2021USE AMENDMENT FILED
Tuesday, August 17, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, July 21, 2021DIVISIONAL REQUEST RECEIVED
Tuesday, August 17, 2021SOU EXTENSION 1 GRANTED
Thursday, July 15, 2021SOU EXTENSION 1 FILED
Monday, August 2, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 15, 2021TEAS REQUEST TO DIVIDE RECEIVED
Thursday, July 15, 2021SOU TEAS EXTENSION RECEIVED
Thursday, July 15, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, June 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, May 29, 2021CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Saturday, May 29, 2021ASSIGNED TO PETITION STAFF
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 6, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 6, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 25, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Saturday, March 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 18, 2021ASSIGNED TO EXAMINER
Sunday, December 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 22, 2020NEW APPLICATION ENTERED

Related Keywords

truseltiq cancer treatment substances preparations pharmaceutical